Military Veterans may be eligible to receive medical care if they participated in U.S. Army chemical or biological substance testing from 1942 to 1975 and have an injury or disease that they [Read more]
The U.S. Army is conducting market research on partnering to accelerate the development of technologies that will enable personnel to assess, protect and mitigate chemical and biological threats. This Request for Information [Read more]
Following the October 2001 confirmation of anthrax in official government mail, a series of screening processes were implemented to safeguard the Pentagon and other Pentagon delegated facilities from biological hazards that might [Read more]
Team Aberdeen Proving Ground (APG) is hosting the APG Discovery Week Advanced Planning Briefing to Industry (APBI) on April 17-20, 2018, at APG, MD. The goal of the APG Discovery Week APBI [Read more]
In support of rapid development of safe and effective radiological/nuclear medical countermeasures for clinical use under emergency situations, the National Institute of Allergy and Infectious Diseases (NIAID) is seeking new or renewal [Read more]
Following the October 2001 confirmation of anthrax in official government mail, a series of screening processes were implemented to safeguard the Pentagon and other Pentagon delegated facilities from biological hazards that might [Read more]
The Defense Logistics Agency Troop Support is soliciting for the supply of Injectable Influenza Vaccine for the 2018-2019 flu season. Approximately 3.6 million doses are included in this requirement. The vaccines shall [Read more]
The Joint Program Executive Office for Chemical and Biological Defense is seeking information on the capabilities of organizations to develop or manufacture a diazepam autoinjector with an anticonvulsant indication against organophosphate poisoning. [Read more]
The Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office (BTO) is sponsoring a Proposers Day in support of the Epigenetic CHaracterization and Observation (ECHO) program. The Proposers Day will be held [Read more]
Therapeutic pharmaceuticals against chemical, biological, radiological and nuclear (CBRN) warfare agents are required to support the Joint Forces across a range of military operations. As such, the U.S. Department of Defense (DoD) [Read more]
© 2018 Global Biodefense